Article

Surgical monovision reasonable alternative for carefully screened presbyopes

Surgical monovision is an attractive option for the patient with presbyopia who seeks refractive surgery and expects glasses- and contact lens-free vision after the procedure, said Mark J. Mannis, MD, at Refractive Surgery 2006.

Surgical monovision is an attractive option for the patient with presbyopia who seeks refractive surgery and expects glasses- and contact lens-free vision after the procedure, said Mark J. Mannis, MD, at Refractive Surgery 2006.

Dr. Mannis, department of ophthalmology, University of California, San Diego, reported the results of a study include 87 patients who underwent LASIK monovision. All were at least 40 years old. Preoperative refractive errors included spherical myopia, myopia with astigmatism, hyperopia, hyperopia with astigmatism, and mixed astigmatism. Thirty-five patients had a contact lens trial preoperatively.

Postoperative, mean SE was 0.02 D in the distance eye and -1.27 D in the near eye.

Overall, 98% of patients were satisfied. Two patients underwent monovision reversal; neither had a preoperative contact lens trial. However, 31 eyes underwent LASIK enhancement, which most often was performed for the distance eye.

"Surgical monovision using LASIK or PRK is a tool many refractive surgeons have used for a long time," Dr. Mannis said. "This study supports its role, but there are some special considerations.

"Practitioners should expect long chair times preoperatively and a relatively high enhancement rate postoperatively because even small amounts of astigmatism may require correction," Dr. Mannis said. "In addition to careful screening and counseling, we also recommend a presurgical contact lens trial for all patients, suggest a minimum 3-week acclimatization period after surgery, and use of 'glove box' glasses for scoptic conditions. In addition, this method is not recommended for certain patients, including pilots or professional drivers."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.